Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

VAC regimen

View Patient Information

A regimen consisting of vincristine, dactinomycin and cyclophosphamide that may be used for the treatment of Ewing sarcoma, mesenchymal chondrosarcoma, rhabdomyosarcoma (RMS), malignant sex cord-stromal tumors and malignant germ cell tumors.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	cyclophosphamide/dactinomycin/vincristine vincristine/actinomycin-D/cyclophosphamide vincristine/dactinomycin/cyclophosphamide
Abbreviation:	VAC

VAC regimen

Search NCI's Drug Dictionary